ANALISIS CITRININ, LOVASTATIN, DAN PIGMEN PADA ANGKAK HASIL FERMENTASI BERAS IR 42 DENGAN MONASCUS PURPUREUS HASIL MUTAGENESIS ETIDIUM BROMIDA
Abstract
Keywords
Full Text:
PDFReferences
Brown, M.S. and Goldstein, J.L. (1991). Drugs Used in The Treatment of
Hiperlipoproteinemia: Pharmacological basis of therapeutics, Ed.8th. New York:
Mc.Graw Hill Book.
Dominguez-Espinoza R. and Webb, C. (2003). Submerge fermentation in wheat
substrates for production of Monascus pigments. World Journal of Microbiology
and Biotechnology, 19, 329-336.
Gusnimar, 2003. Teknik analisis kadar amilosa dalamberas. Buletin Teknik Pertanian,
(2). 41
Grundy, S.M. 1991. Multifactorial etiology of hipercholesterolemia: implication for
prevention of coronary heart disease. Arteriosclerosis and Thrombosis, 11. 1619 –
Heber, D., Yip, I., and Ashley, J.M. (1999). Cholesterol-lowering Effects of a
proprietary Chinese Red-Yeast-Rice Dietary Supplement. Am. J. Clin. Nutr, 69.
-236.
Kasim, E., Kurniawati, Y., and Nurhidayat, N. (2006). Pemanfaatan isolat lokal
Monascus purpureus untuk menurunkan kolesterol darah pada tikus putih galur
Sprangue Dawley. Biodiversitas, 7(2). 122-124.
Pattanagul P, Pinthong, R., Phianmongkhol, and Leksawasdi, N. (2007). Review of
angkak production (Monascus purpureus). Chiang Mai J. Sci, 34(3). 319-328.
Reha, D., Kabelác, M., Ryjácek, F., Sponer, J., Sponer, J.E., Elstner, M., Suhai, S., and
Hobza, P. (2003) Intercalators. 1. Nature of stacking interactions between
intercalators (ethidium, daunomycin, ellipticine, and 4′,6-diaminide-2-phenylindole)
and DNA base pairs. Ab initio quantum chemical, density functional theory, and
empirical potential study. J. Am. Chem. Soc, 124. 3366-76
Shimizu T, Kinoshita, H., Ishihara, S., Sakai, K., Nagai, S., and Nihira, T. 2005.
Polyketide synthetase gene responsible for citrinin biosynthesis in Monascus
purpureus. Applied and Enviromental Microbiology, 71(7). 3453-3457.
Takemoto, M., Node, K., Nakagami, H., Liao, Y., Grimm, M., Takemoto, Y., Kitakaze,
M., and Liao, J.K. (2001). Statin as antioxidant therapy for preventing cardiac
myocyte hypertrophy. J. Clin. Invest, 100. 1429-1437.
License URL: https://creativecommons.org/licenses/by-nc/4.0